CTI officially completed the consolidation and move of multiple offices in Brazil this month, taking a new space in the Água Branca neighborhood in São Paulo. The new Latin American headquarters doubles the amount of space available for the team to work, allowing room for the company's recent and anticipated growth. It is a brand new, state-of-the art build-out, customized to fit the needs of the CTI team and foster the company's award-winning culture. The location provides the team with a wealth of external amenities, including proximity to the train station and a variety of restaurants, and is conveniently located for many of the company's current and prospective partners.
“We’re thrilled for CTI to be starting a new chapter in Água Branca,” remarks Timothy Schroeder, CEO of CTI. “We feel that this location is a perfect fit for our growing team, enabling collaboration and innovation. This site allows us to retain and grow the most talented team in the industry who are helping to develop some of the most innovative life-changing therapies.”
Founded in 1999 by Schroeder and Lynn Fallon, CTI is a global leader in clinical research, working with pharmaceutical and biotechnology companies to plan, manage and analyze clinical trials, a critical step in bringing new drugs, therapies and medical devices to market. The company, with an annual staff retention rate of 95%, is therapeutically focused, specializing in clinical research programs involving critically ill patient populations, and has more than 30 offices worldwide to serve more than 120 pharmaceutical, biotechnology, and medical device clients.